HeartSciences Inc.
About HeartSciences Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $4.3K
- Net income
- -$8.8M
- Total assets
- $4.2M
- Market cap
- $6.2M
Source: SEC EDGAR · updated Jun 8, 2026
- Market cap
- $6.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jun 15, 2022
Market data by Polygon.io · prices are 15-minute delayed
No reviews yet. Be the first to review HeartSciences Inc..